Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
A phase II, comparative, open label, prospective, multicentre clinical trial where each
patient will undergo two procedures; implant of a patch of cultured chimeric skin
(experimental therapy) in a half of the skin lesion and an occlusive non-adherent dressing
(control) in the other half for 12 months of follow-up in two Spanish centres.